Isoflavones - Mechanism of action and impact on breast cancer risk

Breast Care

Volumn 4, Issue 1, 2009, Pages 22-29

  Stubert, Johannes ^a,b   Gerber, Bernd ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Breast cancer; Isoflavones; Nutrition; Phytoestrogens; Prevention; Risk factors

Indexed keywords

COUMESTROL; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR; GENISTEIN; GLYCITEIN; HORMONE ANTAGONIST; ISOFLAVONE DERIVATIVE; LETROZOLE; PHYTOESTROGEN; PLACEBO; TAMOXIFEN; TUMOR MARKER;

ASIAN; BREAST CANCER; BREAST DEVELOPMENT; CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BINDING; DRUG CLASSIFICATION; DRUG INTERACTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; DRUG RESISTANCE; DRUG STRUCTURE; ESTROGEN ACTIVITY; HUMAN; INCIDENCE; META ANALYSIS; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW;

EID: 62849090724     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000200980     Document Type: Review

References (81)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Hanf V, Gonder U: Nutrition and primary prevention of breast cancer: foods, nutrients and breast cancer risk. Eur J Obstet Gynecol Reprod Biol 2005;123:139-149.
3. Nelson HD, Vesco KK, Haney E, Fu R, Nedrow A, Miller J, Nicolaidis C, Walker M, Humphrey L: Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057-2071.
4. Khaodhiar L, Ricciotti HA, Li L, Pan W, Schickel M, Zhou J, Blackburn GL: Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause 2008;15:125-132.
5. Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R: Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas 2007;58:249-258.
6. Korner W, Spengler P, Bolz U, Schuller W, Hanf V, Metzger JW: Substances with estrogenic activity in effluents of sewage treatment plants in southwestern Germany. 2. Biological analysis. Environ Toxicol Chem 2001;20:2142-2151.
7. Korner W, Hanf V, Schuller W, Bartsch H, Zwirner M, Hagenmaier H: Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals. Chemosphere 1998;37:2395-2407.
8. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y: Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001;24:351-356.
9. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, Inoue S, Muramatsu M, Masamune Y: Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull 2002;25:48-52.
10. Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO: Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 2006;101:246-253.
11. De Lemos ML: Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother 2001;35:1118-1121.
12. Brzezinski A, Debi A: Phytoestrogens: the 'natural' selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 1999;85:47-51.
13. Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS: Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol 2008;22:1032-1043.
14. Wang Y, Man GW, Chan FL, Chen S, Leung LK: The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Br J Nutr 2008;99:303-310.
15. Rice S, Whitehead SA: Phytoestrogens and breast cancer - promoters or protectors? Endocr Relat Cancer 2006;13:995-1015.
16. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5595.
17. King-Batoon A, Leszczynska JM, Klein CB: Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 2008;49:36-45.
18. Gerber B, Muller H, Reimer T, Krause A, Friese K: Nutrition and lifestyle factors on the risk of developing breast cancer. Breast Cancer Res Treat 2003;79:265-276.
19. Gerber B, Scholz C, Reimer T, Briese V, Janni W: Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 2006;95:199-209.
20. Edmunds KM, Holloway AC, Crankshaw DJ, Agarwal SK, Foster WG: The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells. Reprod Nutr Dev 2005;45:709-720.
21. Sammartino A, Di Carlo C, Mandato VD, Bifulco G, Di Stefano M, Nappi C: Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecol Endocrinol 2003;17:45-49.
22. Yu ZT, Yao W, Zhu WY: Isolation and identification of equol-producing bacterial strains from cultures of pig faeces. FEMS Microbiol Lett 2008;282:73-80.
23. Halm BM, Franke AA, Ashburn LA, Hebshi SM, Wilkens LR: Oral antibiotics decrease urinary isoflavonoid excretion in children after soy consumption. Nutr Cancer 2008;60:14-22.
24. Nagata C, Ueno T, Uchiyama S, Nagao Y, Yamamoto S, Shibuya C, Kashiki Y, Shimizu H: Dietary and lifestyle correlates of urinary excretion status of equol in Japanese women. Nutr Cancer 2008;60:49-54.
25. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA: Daidzein and genistein contents of vegetables. Br J Nutr 2000;84:717-725.
26. Setchell KD: Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68:1333S-1346S.
27. Chen Z, Zheng W, Custer LJ, Dai Q, Shu XO, Jin F, Franke AA: Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 1999;33:82-87.
28. Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, Lin Y, Nakayama T, Wada M, Ohno Y: Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 1999;33:139-145.
29. Surh J, Kim MJ, Koh E, Kim YK, Kwon H: Estimated intakes of isoflavones and coumestrol in Korean population. Int J Food Sci Nutr 2006;57:325-344.
30. Mulligan AA, Welch AA, McTaggart AA, Bhaniani A, Bingham SA: Intakes and sources of soya foods and isoflavones in a UK population cohort study (EPIC-Norfolk). Eur J Clin Nutr 2007;61:248-254.
31. Boker LK, van der Schouw YT, De Kleijn MJ, Jacques PF, Grobbee DE, Peeters PH: Intake of dietary phytoestrogens by Dutch women. J Nutr 2002;132:1319-1328.
32. De Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, Grobbee DE, Jacques PF: Intake of dietary phytoestrogens is low in post-menopausal women in the United States: the Framingham study(1-4). J Nutr 2001;131:1826-1832.
33. Horn-Ross PL, Lee M, John EM, Koo J: Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control 2000;11:299-302.
34. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE: Dietary effects on breast-cancer risk in Singapore. Lancet 1991;337:1197-1200.
35. Wu AH, Yu MC, Tseng CC, Pike MC: Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008;98:9-14.
36. Wu AH, Koh WP, Wang R, Lee HP, Yu MC: Soy intake and breast cancer risk in Singapore Chinese Health Study. Br J Cancer 2008;99:196-200.
37. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, Miura T, Yamamoto S, Tsugane S: Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 2008;26:1677-1683.
38. Lampe JW, Nishino Y, Ray RM, Wu C, Li W, Lin MG, Gao DL, Hu Y, Shannon J, Stalsberg H, Porter PL, Frankenfeld CL, Wahala K, Thomas DB: Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2007;16:2579-2586.
39. Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR, Jr., Scrafford CG, Barraj LM, Mink PJ, Robien K: Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer 2008;123:664-671.
40. Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E: Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 2008;138:938-945.
41. Travis RC, Allen NE, Appleby PN, Spencer EA, Roddam AW, Key TJ: A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int J Cancer 2008;122:705-710.
42. Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S: Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res 2008;10:R32.
43. Verheus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA, Peeters PH: Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 2007;25:648-655.
44. Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-282.
45. Messina MJ, Wood CE: Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 2008;7:17.
46. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM: Isoflavone treatment for acute menopausal symptoms. Menopause 2007;14:468-473.
47. Sartippour MR, Rao JY, Apple S, Wu D, Henning S, Wang H, Elashoff R, Rubio R, Heber D, Brooks MN: A pilot clinical study of short-term isoflavone supplements in breast cancer patients. Nutr Cancer 2004;49:59-65.
48. Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A, Bundred NJ: Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999;84:4017-4024.
49. Powles TJ, Howell A, Evans DG, McCloskey EV, Ashley S, Greenhalgh R, Affen J, Flook LA, Tidy A: Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause Int 2008;14:6-12.
50. Atkinson C, Warren RM, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA: Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res 2004;6:R170-R179.
51. Maskarinec G, Williams AE, Carlin L: Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 2003;12:165-169.
52. Verheus M, van Gils CH, Kreijkamp-Kaspers S, Kok L, Peeters PH, Grobbee DE, van der Schouw YT: Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008;17:2632-2638.
53. Kataoka M, Atkinson C, Warren R, Sala E, Day NE, Highnam R, Warsi I, Bingham SA: Mammographic density using two computer-based methods in an isoflavone trial. Maturitas 2008;59:350-357.
54. Hsieh CY, Santell RC, Haslam SZ, Helferich WG: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998;58:3833-3838.
55. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG: Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 2001;61:5045-5050.
56. Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG: Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr 2001;131:2957-2962.
57. Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG: Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 2006;27:856-863.
58. Ju YH, Allred KF, Allred CD, Helferich WG: Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 2006;27:1292-1299.
59. Imhof M, Molzer S, Imhof M: Effects of soy isoflavones on 17beta-estradiol-induced proliferation of MCF-7 breast cancer cells. Toxicol In Vitro 2008;22:1452-1460.
60. Yan L, Li D, Yee JA: Dietary supplementation with isolated soy protein reduces metastasis of mammary carcinoma cells in mice. Clin Exp Metastasis 2002;19:535-540.
61. Kim HA, Jeong KS, Kim YK: Soy extract is more potent than genistein on tumor growth inhibition. Anticancer Res 2008;28:2837-2841.
62. Boyapati SM, Shu XO, Ruan ZX, Dai Q, Cai Q, Gao YT, Zheng W: Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study. Breast Cancer Res Treat 2005;92:11-17.
63. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Gaudet MM, Abrahamson PE, Bell P, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD: Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev 2007;16:2285-2292.
64. Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG: Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 2002;62:2474-2477.
65. Limer JL, Parkes AT, Speirs V: Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro. Int J Cancer 2006;119:515-521.
66. Mai Z, Blackburn GL, Zhou JR: Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice. Carcinogenesis 2007;28:1217-1223.
67. Mai Z, Blackburn GL, Zhou JR: Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells. Mol Carcinog 2007;46:534-542.
68. Wu AH, Pike MC, Williams LD, Spicer D, Tseng CC, Churchwell MI, Doerge DR: Tamoxifen, soy, and lifestyle factors in Asian American women with breast cancer. J Clin Oncol 2007;25:3024-3030.
69. Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG: Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 2008;29:2162-2168.
70. Hanf V: Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer: Complementary Therapy and Hormonal Treatment in Breast Cancer Survivors and (Plant) Alternatives and Survivorship. www.ago-online.de/ download/g-mamma-08-1-1-c-25-complementary-therapy-hrt-survivorship.pdf. Version 2008; Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma.
71. Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT, Zheng W: Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001;10:483-488.
72. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC: Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002;23:1491-1496.
73. Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU: Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006;17:1253-1261.
74. Boucher BA, Cotterchio M, Kreiger N, Thompson LU: Soy formula and breast cancer risk. Epidemiology 2008;19:165-166.
75. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L: The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 2008;98:1485-1493.
76. Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH: Breast differentiation and its implication in cancer prevention. Clin Cancer Res 2005;11:931s-936s.
77. Sivaraman L, Stephens LC, Markaverich BM, Clark JA, Krnacik S, Conneely OM, O'Malley BW, Medina D: Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis 1998;19:1573-1581.
78. Hilakivi-Clarke L: Nutritional modulation of terminal end buds: its relevance to breast cancer prevention. Curr Cancer Drug Targets 2007;7:465-474.
79. Gammon MD, Fink BN, Steck SE, Wolff MS: Soy intake and breast cancer: elucidation of an unanswered question. Br J Cancer 2008;98:2-3.
80. Bosetti C, Spertini L, Parpinel M, Gnagnarella P, Lagiou P, Negri E, Franceschi S, Montella M, Peterson J, Dwyer J, Giacosa A, La Vecchia C: Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 2005;14:805-808.
81. Wang H, Murphy PA: Isoflavone Content in Commercial Soybean Foods. J Agric Food Chem 1994;42:1666-1673.